Cargando…

Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases

AIM: To investigate whether immune mediated diseases (IMD) are more frequent in patients with inflammatory bowel disease (IBD). METHODS: In this population based registry study, a total of 47325 patients with IBD were alive and registered in the Danish National Patient Registry on December 16, 2013....

Descripción completa

Detalles Bibliográficos
Autores principales: Halling, Morten L, Kjeldsen, Jens, Knudsen, Torben, Nielsen, Jan, Hansen, Lars Koch
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597505/
https://www.ncbi.nlm.nih.gov/pubmed/28970729
http://dx.doi.org/10.3748/wjg.v23.i33.6137
_version_ 1783263715701817344
author Halling, Morten L
Kjeldsen, Jens
Knudsen, Torben
Nielsen, Jan
Hansen, Lars Koch
author_facet Halling, Morten L
Kjeldsen, Jens
Knudsen, Torben
Nielsen, Jan
Hansen, Lars Koch
author_sort Halling, Morten L
collection PubMed
description AIM: To investigate whether immune mediated diseases (IMD) are more frequent in patients with inflammatory bowel disease (IBD). METHODS: In this population based registry study, a total of 47325 patients with IBD were alive and registered in the Danish National Patient Registry on December 16, 2013. Controls were randomly selected from the Danish Civil Registration System (CRS) and matched for sex, age, and municipality. We used ICD 10 codes to identify the diagnoses of the included patients. The IBD population was divided into three subgroups: Ulcerative colitis (UC), Crohn’s disease (CD) and Both the latter referring to those registered with both diagnoses. Subsequently, odds-ratios (OR) and 95%CI were obtained separately for each group and their respective controls. The use of Bonferoni post-test correction adjusted the significance level to P < 0.00125. P-values were estimated using Fisher’s exact test. RESULTS: There were significantly more women than men in the registry, and a greater percentage of comorbidity in the IBD groups (P < 0.05). Twenty different IMDs were all significantly more frequent in the IBD group. Sixteen were associated with UC versus twelve with CD. In both UC and CD ORs were significantly increased (P < 0.00125) for primary sclerosing cholangitis (PSC), celiac disease, type 1 diabetes (T1D), sarcoidosis, asthma, iridocyclitis, psoriasis, pyoderma gangrenosum, rheumatoid arthritis, and ankylosing spondylitis. Restricted to UC (P < 0.00125) were autoimmune hepatitis, primary biliary cholangitis, Grave’s disease, polymyalgia rheumatica, temporal arteritis , and atrophic gastritis. Restricted to CD (P < 0.00125) were psoriatic arthritis and episcleritis. Restricted to women with UC (P < 0.00125) were atrophic gastritis, rheumatoid arthritis, temporal arteritis, and polymyalgia rheumatica. Restricted to women with CD were episcleritis, rheumatoid arthritis, and psoriatic arthritis. The only disease restricted to men (P < 0.00125) was sarcoidosis. CONCLUSION: Immune mediated diseases were significantly more frequent in patients with IBD. Our results strengthen the hypothesis that some IMDs and IBD may have overlapping pathogenic pathways.
format Online
Article
Text
id pubmed-5597505
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-55975052017-10-02 Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases Halling, Morten L Kjeldsen, Jens Knudsen, Torben Nielsen, Jan Hansen, Lars Koch World J Gastroenterol Retrospective Study AIM: To investigate whether immune mediated diseases (IMD) are more frequent in patients with inflammatory bowel disease (IBD). METHODS: In this population based registry study, a total of 47325 patients with IBD were alive and registered in the Danish National Patient Registry on December 16, 2013. Controls were randomly selected from the Danish Civil Registration System (CRS) and matched for sex, age, and municipality. We used ICD 10 codes to identify the diagnoses of the included patients. The IBD population was divided into three subgroups: Ulcerative colitis (UC), Crohn’s disease (CD) and Both the latter referring to those registered with both diagnoses. Subsequently, odds-ratios (OR) and 95%CI were obtained separately for each group and their respective controls. The use of Bonferoni post-test correction adjusted the significance level to P < 0.00125. P-values were estimated using Fisher’s exact test. RESULTS: There were significantly more women than men in the registry, and a greater percentage of comorbidity in the IBD groups (P < 0.05). Twenty different IMDs were all significantly more frequent in the IBD group. Sixteen were associated with UC versus twelve with CD. In both UC and CD ORs were significantly increased (P < 0.00125) for primary sclerosing cholangitis (PSC), celiac disease, type 1 diabetes (T1D), sarcoidosis, asthma, iridocyclitis, psoriasis, pyoderma gangrenosum, rheumatoid arthritis, and ankylosing spondylitis. Restricted to UC (P < 0.00125) were autoimmune hepatitis, primary biliary cholangitis, Grave’s disease, polymyalgia rheumatica, temporal arteritis , and atrophic gastritis. Restricted to CD (P < 0.00125) were psoriatic arthritis and episcleritis. Restricted to women with UC (P < 0.00125) were atrophic gastritis, rheumatoid arthritis, temporal arteritis, and polymyalgia rheumatica. Restricted to women with CD were episcleritis, rheumatoid arthritis, and psoriatic arthritis. The only disease restricted to men (P < 0.00125) was sarcoidosis. CONCLUSION: Immune mediated diseases were significantly more frequent in patients with IBD. Our results strengthen the hypothesis that some IMDs and IBD may have overlapping pathogenic pathways. Baishideng Publishing Group Inc 2017-09-07 2017-09-07 /pmc/articles/PMC5597505/ /pubmed/28970729 http://dx.doi.org/10.3748/wjg.v23.i33.6137 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial.
spellingShingle Retrospective Study
Halling, Morten L
Kjeldsen, Jens
Knudsen, Torben
Nielsen, Jan
Hansen, Lars Koch
Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
title Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
title_full Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
title_fullStr Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
title_full_unstemmed Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
title_short Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
title_sort patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5597505/
https://www.ncbi.nlm.nih.gov/pubmed/28970729
http://dx.doi.org/10.3748/wjg.v23.i33.6137
work_keys_str_mv AT hallingmortenl patientswithinflammatoryboweldiseasehaveincreasedriskofautoimmuneandinflammatorydiseases
AT kjeldsenjens patientswithinflammatoryboweldiseasehaveincreasedriskofautoimmuneandinflammatorydiseases
AT knudsentorben patientswithinflammatoryboweldiseasehaveincreasedriskofautoimmuneandinflammatorydiseases
AT nielsenjan patientswithinflammatoryboweldiseasehaveincreasedriskofautoimmuneandinflammatorydiseases
AT hansenlarskoch patientswithinflammatoryboweldiseasehaveincreasedriskofautoimmuneandinflammatorydiseases